Cargando…
Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs
Alzheimer’s disease (AD) is the most common age-dependent neurodegenerative disease which impairs cognitive function and gradually causes patients to be unable to lead normal daily lives. While the etiology of AD remains an enigma, excessive accumulation of β-amyloid peptide (Aβ) is widely believed...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944430/ https://www.ncbi.nlm.nih.gov/pubmed/27418961 http://dx.doi.org/10.1186/s40035-016-0061-5 |